Invention Grant
- Patent Title: CHIKV RNA vaccines
-
Application No.: US16009880Application Date: 2018-06-15
-
Publication No.: US10702597B2Publication Date: 2020-07-07
- Inventor: Giuseppe Ciaramella , Eric Yi-Chun Huang , Kapil Bahl , Tal Zaks , Sunny Himansu , Sayda Mahgoub Elbashir
- Applicant: ModernaTX, Inc.
- Applicant Address: US MA Cambridge
- Assignee: ModernaTX, Inc.
- Current Assignee: ModernaTX, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: A61K39/12
- IPC: A61K39/12 ; C07K14/005 ; A61K9/14 ; A61K9/00 ; C07K16/28 ; C07K16/10 ; A61K47/10 ; A61K47/18 ; A61K47/22 ; A61K47/28 ; C12N7/00 ; A61P31/12 ; A61P31/14 ; A61K9/51 ; A61K39/00
Abstract:
Aspects of the disclosure relate to nucleic acid vaccines. The vaccines include one or more RNA polynucleotides having an open reading frame encoding one or more Chikungunya antigen(s), one or more Zika virus antigens, and one or more Dengue antigens. Methods for preparing and using such vaccines are also described.
Public/Granted literature
- US20180344839A1 CHIKV RNA VACCINES Public/Granted day:2018-12-06
Information query
